HCW Biologics Inc. (HCWB)
1.60
+0.07
(+4.58%)
USD |
NASDAQ |
Oct 09, 16:00
1.65
+0.05
(+3.12%)
After-Hours: 20:00
HCW Biologics Price : 1.60 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 1.60 | 1.728 | 1.52 | 1.60 | 79975.00 |
| Oct 08, 2026 | 1.59 | 1.61 | 1.51 | 1.53 | 46376.00 |
| Oct 07, 2026 | 1.55 | 1.62 | 1.54 | 1.56 | 30681.00 |
| Oct 06, 2026 | 1.61 | 1.63 | 1.55 | 1.57 | 37825.00 |
| Oct 05, 2026 | 1.64 | 1.69 | 1.55 | 1.64 | 83290.00 |
| Oct 02, 2026 | 1.66 | 1.721 | 1.65 | 1.68 | 66529.00 |
| Oct 01, 2026 | 1.747 | 1.747 | 1.671 | 1.69 | 55702.00 |
| Sep 30, 2026 | 1.77 | 1.823 | 1.71 | 1.71 | 48410.00 |
| Sep 29, 2026 | 1.81 | 1.85 | 1.75 | 1.75 | 52063.00 |
| Sep 28, 2026 | 1.86 | 1.895 | 1.71 | 1.82 | 104526.0 |
| Sep 25, 2026 | 1.88 | 2.00 | 1.81 | 1.93 | 418789.0 |
| Sep 24, 2026 | 1.69 | 3.12 | 1.67 | 1.99 | 13.67M |
| Sep 23, 2026 | 1.81 | 1.83 | 1.610 | 1.66 | 161354.0 |
| Sep 22, 2026 | 1.91 | 1.98 | 1.70 | 1.81 | 133709.0 |
| Sep 21, 2026 | 1.95 | 2.02 | 1.87 | 1.91 | 59231.00 |
| Sep 18, 2026 | 2.00 | 2.150 | 1.87 | 1.87 | 87620.00 |
| Sep 17, 2026 | 2.05 | 2.074 | 1.94 | 1.95 | 67699.00 |
| Sep 16, 2026 | 2.09 | 2.10 | 1.89 | 2.01 | 86469.00 |
| Sep 15, 2026 | 2.17 | 2.189 | 2.05 | 2.05 | 55473.00 |
| Sep 14, 2026 | 2.240 | 2.325 | 2.18 | 2.20 | 100025.0 |
| Sep 11, 2026 | 2.43 | 2.445 | 2.16 | 2.24 | 94710.00 |
| Sep 10, 2026 | 2.42 | 2.52 | 2.41 | 2.43 | 31761.00 |
| Sep 09, 2026 | 2.44 | 2.53 | 2.34 | 2.46 | 102291.0 |
| Sep 08, 2026 | 2.52 | 2.72 | 2.10 | 2.51 | 3.088M |
| Sep 04, 2026 | 2.81 | 2.97 | 2.80 | 2.94 | 37298.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 62.75 |
| Oncolytics Biotech, Inc. | 0.557 |
| Sangamo Therapeutics, Inc. | 0.1478 |
| Sarepta Therapeutics, Inc. | 17.85 |
| Anixa Biosciences, Inc. | 2.90 |
Price Related Metrics
| PS Ratio | 0.1888 |
| Price to Book Value | 0.3485 |
| Earnings Yield | -1.78K% |
| Market Cap | 2.588M |